Global Med Ranks 35th With 57.2% Revenue Growth DENVER, Oct. 10 /PRNewswire-FirstCall/ -- Global Med Technologies, Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) has been named in Deloitte's prestigious Technology Fast 50 Program for Colorado, a ranking of the 50 fastest growing technology companies in the state by Deloitte & Touche USA LLP, one of the nation's leading professional services organizations. Rankings are based on the percentage revenue growth over five years from 2000-2004. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) Global Med's CEO Dr. Mick Ruxin said, "We are delighted to have been chosen by Deloitte's Colorado Technology Fast 50. This accolade demonstrates the hard work and success Global Med has achieved over the past 5 years and we look forward to building on this in the future." Global Med's increase in revenues of 57.2% from 2000 to 2004 resulted in a 35th ranking in the Technology Fast 50 for Colorado. Steve Yaroch, Technology, Media and Telecommunications Group Leader for Deloitte & Touche LLP in Denver and Chair of the 2005 Colorado Technology Fast 50, said, "Sustaining high revenue growth over five years is an exceptional accomplishment. We commend Global Med for making the commitment to technology and delivering on the promise of market longevity. We are proud to honor Global Med as a Deloitte Colorado Technology Fast 50 winner." About Global Med Technologies, Inc. Global Med Technologies, Inc. is an international e-Health, medical information technology company, providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Current clients of Wyndgate's products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Wyndgate's products are also being implemented in Canada, the Caribbean and sub-Saharan Africa. Together, the SafeTrace(R) donor management system and the SafeTrace Tx(R)* advanced transfusion management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. About Deloitte Deloitte & Touche USA LLP is the US member firm of Deloitte Touche Tohmatsu. In the US, services are provided by the subsidiaries of Deloitte & Touche USA LLP (Deloitte & Touche LLP, Deloitte Consulting LLP, Deloitte Financial Advisory Services LLP, Deloitte Tax LLP and their subsidiaries), and not by Deloitte & Touche USA LLP. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. *Patent Pending http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies, Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies(R), Inc., +1-303-238-2000; or Investors, John Nesbett or Sally Martin, both of The Investor Relations Group, +1-212-825-3210, for Global Med Technologies, Inc. Web site: http://www.wyndgate.com/ Web site: http://www.peoplemed.com/ Web site: http://www.globalmedtech.com/

Copyright